文献速递血栓与止血

癌症相关血栓形成:提高认识与病理生理复杂性

Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity.
PubMed 文献 · J Thromb Haemost · 2023-03-15

本文综述癌症相关血栓形成的病理生理复杂性与认识进展,涵盖静脉与动脉血栓、凝血与肿瘤生物学交互、国际指南中的预防治疗策略,以及患者与肿瘤异质性及新型抗癌药带来的挑战,呼吁提高医患认识。

要点

  • 静脉与动脉血栓是癌症患者致病和死亡的主要原因之一。
  • 凝血通路与肿瘤生物学联系密切,不断有新参与者被识别。
  • 癌症患者血栓预防治疗已纳入国际指南,但个体异质性仍使该领域面临挑战。

核心结论

  • 癌症相关血栓形成领域仍是一个开放挑战,源于癌症患者个人病史、心血管危险因素、肿瘤类型部位分期及新型抗癌药使用的内在异质性。

研究设计与样本

  • 综述,检索范围与纳入文献数原文未报告。

主要发现

  • 静脉与动脉血栓是癌症患者致病和死亡的主要原因之一。
  • 癌症相关易栓症的分子基础研究可追溯至2个世纪前首次观察到循环微血栓中存在肿瘤细胞。
  • 凝血通路与肿瘤生物学的深刻联系不断被揭示,复杂交互中的新参与者已被识别。
  • 癌症患者血栓的不良影响及较非癌人群更高的出血风险,促使多年来开展大型临床研究以采用最佳静脉血栓栓塞症预防和治疗策略。

关键数值与推荐

  • 静脉血栓栓塞症的最佳预防和治疗策略已纳入专门的国际指南。
  • 原文未报告具体推荐等级、剂量或阈值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thrombosis, both venous and arterial, is a leading cause of morbidity and mortality in patients with cancer. Studies on the molecular basis of cancer-associated thrombophilia have a long story starting from the first observation of the presence of tumor cells in circulating microthrombi 2 centuries ago. The profound link between pathways of blood coagulation and tumor biology has been more and more unraveled, and new actors in this complex interaction have been identified. The unfavorable impact of thrombosis in a patient with cancer, on which also hangs a high bleeding risk as compared to the noncancer population, has led during years to the production of large clinical studies to adopt the best prophylaxis and treatment strategies of venous thromboembolism in different medical and surgical settings, now incorporated in dedicated international guidelines. This field, however, still represents an open challenge due to the intrinsic variability of the patient with cancer with his/her personal medical history and cardiovascular risk factors, as well as the type, site and stage of the tumor, and the use of a wide array of new sophisticated anticancer drugs. This review aims to highlight some of the many key observations in the field of cancer and thrombosis, spanning the scope from fundamental tumor biology to advanced clinical trials of new anticoagulants. We hope that some of the examples we have included will inspire readers to explore and discuss these topics, thereby increasing awareness of cancer-related thrombosis in both physicians and patients.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Falanga A, Marchetti M. Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. J Thromb Haemost. 2023. PMID: 36931602. doi:10.1016/j.jtha.2023.02.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。